In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues that will be addressed at the upcoming FDA town hall.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.